Cyclosporine from twice to single daily dosing: Impact on renal function, mortality, and graft loss

Transplantation Proceedings

Volumn 34, Issue 7, 2002, Pages 2920-2921

  Bianco, P D ^a   Silva, H T ^a   Boni, R ^a   Machado, P G P ^a   Pacheco Silva, A ^a   Pestana, J O M ^a  

^a NONE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; CYCLOSPORIN A; PREDNISONE;

ADULT; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DRUG DISTRIBUTION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; ENZYME ANALYSIS; FEMALE; FOLLOW UP; GRAFT REJECTION; GRAFT SURVIVAL; HEART GRAFT; HEMODIALYSIS; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INTERMETHOD COMPARISON; ISCHEMIA; KIDNEY DONOR; KIDNEY FUNCTION; KIDNEY GRAFT; KIDNEY TUBULE NECROSIS; MAJOR CLINICAL STUDY; MALE; MICROEMULSION; NEPHROTOXICITY; OPTIMAL DRUG DOSE; PRIORITY JOURNAL; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICAL ANALYSIS; STATISTICAL MODEL; SURGICAL MORTALITY; TREATMENT OUTCOME;

CREATININE; CYCLOSPORINE; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TREATMENT FAILURE;

EID: 0036842789     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(02)03488-7     Document Type: Article

References (5)

1. Mourad G., Vela C., Ribstein J., Mimran A. Transplantation. 65:1998;661.
2. Belitsky P., Dunn S., Johnston A., Levy G. Clin Pharmacokinetic. 39:2000;117.
3. Bunke M., Sloan R., Brier M., et al. Transplantation. 60:1995;1376.
4. Mattos AM, Olyaei AJ, Barry JM, et al: Presented at the Scientific Meeting of the AST, Chicago, IL, USA, May 1999.
5. Hopkins WG: Available from: URL http:www.davidmlane.com/hyperstat/index.html 1997 (Retrieved December, 2001).